Thus, we demonstrated both non-cell autonomous function of cancer cell-expressed mutant p53, by inducing the IFN-β response in adjacent stromal cells, as well as modulation of the IFN-β signal by mutant p53, in a way that benefits the tumor cells. This evidence concerns the gene TP53 and neoplasm.